10x Genomics, Inc.
71.55USD
+1.8000 (+2.58%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TXG.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.02▲ | -$0.04 | 2 | 0 |
| Next quarter | -$0.01▲ | -$0.01 | 1 | 1 |
| Current year | $0.04▲ | $0 | 1 | 0 |
| Next year | $0.08▼ | $0.21 | 1 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.02 | $0.03 | +0.04 (+258.4%) |
| 2026-03-31 | -$0.06 | $0.07 | +0.13 (+219.2%) |
| 2025-12-31 | -$0.04 | $0.07 | +0.11 (+276.3%) |
| 2025-09-30 | -$0.07 | -$0.02 | +0.05 (+67.4%) |
161 ratings from 22 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $47 $70 | Oct 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $40 $70 | Oct 13, 2026 |
| Canaccord Genuity | Maintained | Buy | $60 $100 | Oct 12, 2026 |
| Barclays | Maintained | Overweight | $52 $110 | Oct 7, 2026 |
| Leerink Partners | Maintained | Market Perform | $40 $90 | Sep 29, 2026 |
| Piper Sandler | Maintained | Neutral | $47 $80 | Sep 28, 2026 |
| Argus Research | Initiated | Buy | $110 | Sep 28, 2026 |
| UBS | Maintained | Neutral | $20 $68 | Sep 9, 2026 |
| RBC Capital | Initiated | Sector Perform | $70 | Sep 1, 2026 |
| Stephens & Co. | Maintained | Overweight | $50 $65 | Aug 12, 2026 |
| Piper Sandler | Maintained | Neutral | $42 $47 | Aug 10, 2026 |
| Canaccord Genuity | Maintained | Buy | $50 $60 | Aug 10, 2026 |
| Citigroup | Maintained | Neutral | $45 $50 | Aug 7, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $37 $40 | Aug 7, 2026 |
| Leerink Partners | Maintained | Market Perform | $23 $40 | Jul 17, 2026 |
| Canaccord Genuity | Maintained | Buy | $32 $50 | Jul 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $22 $37 | Jul 9, 2026 |
| Citigroup | Maintained | Neutral | $24 $45 | Jul 8, 2026 |
| Piper Sandler | Maintained | Neutral | $20 $42 | Jul 1, 2026 |
| Barclays | Maintained | Overweight | $30 $40 | Jun 24, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $20 $22 | May 12, 2026 |
| JP Morgan | Maintained | Neutral | $17 $20 | May 12, 2026 |
| Canaccord Genuity | Maintained | Buy | $22 $32 | Apr 20, 2026 |
| B of A Securities | Maintained | Neutral | $21 $30 | Apr 20, 2026 |
| Barclays | Maintained | Overweight | $22 $30 | Apr 14, 2026 |
80 filings from 11 insiders · 8 buy / 16 sell over 6m
Officers and directors of TXG, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SULIMAN SHEHNAAZDirector | Sell | 1.2k | $82.28 | $101k | Sep 22, 2026 |
| SULIMAN SHEHNAAZDirector | Sell | 2.3k | $81.67 | $185k | Sep 22, 2026 |
| SULIMAN SHEHNAAZDirector | Sell | 1.3k | $80.82 | $107k | Sep 22, 2026 |
| SULIMAN SHEHNAAZDirector | Sell | 614 | $79.51 | $49k | Sep 22, 2026 |
| SULIMAN SHEHNAAZDirector | Sell | 292 | $78.20 | $23k | Sep 22, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Sell | 2.8k | $82.36 | $231k | Sep 22, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Sell | 9.9k | $81.83 | $810k | Sep 22, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Sell | 9.3k | $80.90 | $752k | Sep 22, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Sell | 2.0k | $79.62 | $159k | Sep 22, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Sell | 1.0k | $78.23 | $78k | Sep 22, 2026 |
| Taich AdamOfficer, Chief Financial Officer | Sell | 13.8k | $65.26 | $898k | Sep 9, 2026 |
| Taich AdamOfficer, Chief Financial Officer | Sell | 31.4k | $64.31 | $2.02M | Sep 9, 2026 |
| Taich AdamOfficer, Chief Financial Officer | Sell | 1.2k | $63.68 | $77k | Sep 9, 2026 |
| STUELPNAGEL JOHN RDirector | Sell | 6.2k | $62.61 | $387k | Sep 3, 2026 |
| STUELPNAGEL JOHN RDirector | Sell | 6.8k | $62.11 | $423k | Sep 3, 2026 |
| STUELPNAGEL JOHN RDirector | Sell | 7.0k | $60.66 | $425k | Sep 3, 2026 |
| Saxonov SergeDirector; Officer, Chief Executive Officer | Gift | 100 | — | — | Sep 1, 2026 |
| SAXONOV SERGE WILSONChief Executive Officer | Sell | 10.5k | $63.02 | $668k | Aug 26, 2026 |
| SAXONOV SERGE WILSONChief Executive Officer | Sell | 18.5k | $63.02 | $1.17M | Aug 24, 2026 |
| SULIMAN SHEHNAAZDirector | Sell | 2.2k | $62.73 | $140k | Aug 24, 2026 |
No analyst notes on TXG yet.
Analyst Ratings
14 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 5 | 12 | 0 | 0 | Hold2.61 |
| 1 mo ago | 1 | 6 | 12 | 0 | 0 | Hold2.58 |
| 2 mo ago | 1 | 5 | 10 | 0 | 0 | Hold2.56 |
| 3 mo ago | 1 | 5 | 10 | 0 | 0 | Hold2.56 |
Members whose judged calls on TXG have played out most reliably.
No settled calls on TXG yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice